State of Wisconsin Investment Board
IMDX

State of Wisconsin Investment Board’s Insight Molecular Diagnostics IMDX Stock Holding History

State of Wisconsin Investment Board’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,930
Closed -$127K – 2398
2021
Q4 		$127K Sell
2,930
-5,145
-64% -$296K ﹤0.01% 2112
2021
Q3 		$575K Buy
8,075
+3,026
+60% +$278K ﹤0.01% 1651
2021
Q2 		$580K Buy
5,049
+1,744
+53% +$170K ﹤0.01% 1644
2021
Q1 		$343K Buy
+3,305
New +$314K ﹤0.01% 1753

Other funds holding IMDX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State of Wisconsin Investment Board's IMDX Position: Q1 2022 in Review

State of Wisconsin Investment Board sold out of Insight Molecular Diagnostics (IMDX) in Q1 2022, closing a stake of 2,930 shares — an estimated $127K sold.

State of Wisconsin Investment Board first reported a position in IMDX in Q1 2021 and held it in 4 quarters. The position peaked at $580K in Q2 2021. 86 funds tracked by Wall St. Rank hold IMDX as of Q1 2022.

  • State of Wisconsin Investment Board reported no remaining Insight Molecular Diagnostics position as of Q1 2022 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 2,930 Insight Molecular Diagnostics shares in Q1 2022, an estimated $127K.
  • State of Wisconsin Investment Board first reported a position in Insight Molecular Diagnostics in Q1 2021 and held it in 4 quarters.
  • State of Wisconsin Investment Board's Insight Molecular Diagnostics position peaked at $580K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q1 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2022, filed 13 May 2022.